17 November 2023 in Biofabrication
Meniscus injuries are a common problem in orthopedic medicine and are associated with a significantly increased risk of developing osteoarthritis. While developments have been made in the field of meniscus regeneration, the engineering of cell-laden constructs that mimic the complex structure, composition and biomechanics of the native tissue remains a significant challenge. This can be linked to the use of cells that are not phenotypically representative of the different zones of the meniscus, and an inability to direct the spatial organization of engineered meniscal tissues. In this study we investigated the potential of zone-specific meniscus progenitor cells (MPCs) to generate functional meniscal tissue following their deposition into melt electrowritten (MEW) scaffolds. We first confirmed that fibronectin selected MPCs from the inner and outer regions of the meniscus maintain their differentiation capacity with prolonged monolayer expansion, opening their use within advanced biofabrication strategies. By depositing MPCs within MEW scaffolds with elongated pore shapes, which functioned as physical boundaries to direct cell growth and extracellular matrix production, we were able to bioprint anisotropic fibrocartilaginous tissues with preferentially aligned collagen networks. Furthermore, by using MPCs isolated from the inner (iMPCs) and outer (oMPCs) zone of the meniscus, we were able to bioprint phenotypically distinct constructs mimicking aspects of the native tissue. An iterative MEW process was then implemented to print scaffolds with a similar wedged-shaped profile to that of the native meniscus, into which we deposited iMPCs and oMPCs in a spatially controlled manner. This process allowed us to engineer sulfated glycosaminoglycan and collagen rich constructs mimicking the geometry of the meniscus, with MPCs generating a more fibrocartilage-like tissue compared to the mesenchymal stromal/stem cells. Taken together, these results demonstrate how the convergence of emerging biofabrication platforms with tissue-specific progenitor cells can enable the engineering of complex tissues such as the meniscus.
6 September 2024 in ACS Biomaterials Science & Engineering
In recent years, there has been increased interest in the use of cellular spheroids, microtissues, and organoids as biological building blocks to engineer functional tissues and organs. Such microtissues are typically formed by the self-assembly of cellular aggregates and the subsequent deposition of a tissue-specific extracellular matrix (ECM). Biofabrication and 3D bioprinting strategies using microtissues may require the development of supporting hydrogels and bioinks to spatially localize such biological building blocks in 3D space and hence enable the engineering of geometrically defined tissues. Therefore, the aim of this work was to engineer scaled-up, geometrically defined cartilage grafts by combining multiple cartilage microtissues within a rapidly degrading oxidized alginate (OA) supporting hydrogel and maintaining these constructs in dynamic culture conditions. To this end, cartilage microtissues were first independently matured for either 2 or 4 days and then combined in the presence or absence of a supporting OA hydrogel. Over 6 weeks in static culture, constructs engineered using microtissues that were matured independently for 2 days generated higher amounts of glycosaminoglycans (GAGs) compared to those matured for 4 days. Histological analysis revealed intense staining for GAGs and negative staining for calcium deposits in constructs generated by using the supporting OA hydrogel. Less physical contraction was also observed in constructs generated in the presence of the supporting gel; however, the remnants of individual microtissues were more observable, suggesting that even the presence of a rapidly degrading hydrogel may delay the fusion and/or the remodeling of the individual microtissues. Dynamic culture conditions were found to modulate ECM synthesis following the OA hydrogel encapsulation. We also assessed the feasibility of 3D bioprinting of cartilage microtissues within OA based bioinks. It was observed that the microtissues remained viable after extrusion-based bioprinting and were able to fuse after 48 h, particularly when high microtissue densities were used, ultimately generating a cartilage tissue that was rich in GAGs and negative for calcium deposits. Therefore, this work supports the use of OA as a supporting hydrogel/bioink when using microtissues as biological building blocks in diverse biofabrication and 3D bioprinting platforms.
21 August 2025 in Advanced Healthcare Materials
Meniscal injuries are common orthopaedic problems which can impair knee function and lead to the development of osteoarthritis. While recent advances in tissue engineering have enabled the fabrication of meniscus‐like grafts, these do not fully replicate the zonal structure and composition of the native meniscus. Here, fibrocartilage microtissues are used as building blocks to biofabricate zonally defined meniscal grafts. Meniscus progenitor cells (MPCs) isolated from the inner (iMPC) and outer (oMPC) regions of caprine menisci are used to engineer region‐specific meniscal microtissues. Both iMPC and oMPC‐derived microtissues are rich in glycosaminoglycans (GAGs) and collagen, with iMPC‐derived microtissues staining more intensely for type II collagen. These microtissues are assembled into two different physically confining moulds, where they rapidly fuse and generate a fibrocartilaginous graft. The impact of the catabolic enzyme chondroitinase‐ABC (cABC) on the composition and structural organization of the meniscal grafts is then explored, which is found to reduce sGAG levels but to increase collagen fiber thickness. Finally, iMPC and oMPC microtissues are spatially assembled to biofabricate a scaled‐up and zonally defined meniscal construct. These findings support the use of MPC‐derived microtissues as biological building blocks for the engineering of meniscal grafts.
31 August 2026 in bioRxiv
Osteochondral repair requires restoration of zonally organised articular cartilage and subchondral bone, yet translatable implants rarely reproduce this spatial complexity. Here, we developed an acellular multilayer scaffold comprising a superficial 2% (w/v) articular cartilage extracellular matrix (AC-ECM) phase, an intermediate 5% AC-ECM phase and a basal 6% bone ECM (BN-ECM) phase. The scaffold formed continuous interfaces, displayed region-dependent pore architecture and showed limited residual deformation after compression. In vitro, constructs seeded with caprine mesenchymal stromal and articular cartilage progenitor cells supported cell expansion and the accumulation of sulfated glycosaminoglycan- and collagen-rich matrix, with regional differences in collagen I, II and X immunoreactivity. Following eight weeks of subcutaneous implantation, cell-seeded scaffolds contained more collagenous matrix than unseeded controls, while vascularisation preferentially localised to the BN-ECM phase. In a six-month caprine osteochondral defect model, scaffold treatment significantly improved macroscopic and histological repair and increased PTA-attenuating, collagen-rich repair-tissue fill within the chondral region (∼60% versus ∼40%). It also limited extension of this tissue into the subchondral region and produced superficial collagen fibres more closely aligned parallel to the articular surface. Repair tissue exhibited greater collagen II immunoreactivity, increased ACAN and COL2A1 expression and reduced COL10A1 expression, whereas deeper mineralised tissue formation was not significantly improved. These findings demonstrate that this acellular multilayer ECM scaffold improves the cartilage component of osteochondral repair without exogenous cells or growth factors and identify subchondral bone regeneration as the principal remaining design challenge.